Clinical Trial Update: The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study [Phase 2]

View source ↗

Summary

The ELDORADO study is a Phase 2 trial evaluating Eligard (leuprolide acetate) with docetaxel and radiotherapy for prostate cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Eligard (leuprolide acetate)

Snippet

Sponsor: Nova Scotia Cancer Centre | Conditions: Prostatic Neoplasms | Phase 2 | Status: UNKNOWN